Trial intelligence / Profile preview

Bioequivalence of INNOXOSTAT vs Feburic 80 mg under fasting in healthy Thai volunteers

TCTR20241122011Phase 1Unknown

Sponsor
International Bio Service
Start
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of febuxostat in gout (2 arms), sponsored by International Bio Service. Status: unknown.

02

Drugs

febuxostat
03

Conditions

gout

Beyond the preview

Go deeper on TCTR20241122011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20241122011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call